Company Filing History:
Years Active: 2017
Title: Yayoi Shimada: Innovator in Immunosuppressive Antibodies
Introduction
Yayoi Shimada is a prominent inventor based in Kisarazu, Japan. She has made significant contributions to the field of immunology through her innovative research and development of monoclonal antibodies. Her work focuses on creating antibodies with immunosuppressive activity, which can have profound implications in medical treatments.
Latest Patents
Yayoi Shimada holds a patent for a monoclonal antibody that exhibits excellent immunosuppressive activity. The patent describes a monoclonal antibody or an antigen binding fragment that binds to a peptide with the amino acid sequence represented by SSVLYGGPPSAA (SEQ ID NO: 1). This invention is particularly noteworthy as it demonstrates a higher binding affinity for core histone compared to histone H1. This advancement could lead to new therapeutic options for conditions requiring immunosuppression.
Career Highlights
Yayoi Shimada is affiliated with Josai University Corporation, where she continues her research and development efforts. Her dedication to advancing the field of immunology is evident in her innovative approaches and the successful patenting of her work. With a focus on practical applications, she aims to translate her research into real-world medical solutions.
Collaborations
Yayoi collaborates with esteemed colleagues, including Shuji Sato and Takeshi Goto. These partnerships enhance her research capabilities and contribute to the advancement of their shared goals in immunology.
Conclusion
Yayoi Shimada's contributions to the field of immunology through her patented monoclonal antibody highlight her role as an influential inventor. Her work not only showcases her innovative spirit but also holds the potential to impact medical treatments significantly.